Mobic

Basic Mobic Information

• INN (International Nonproprietary Name): Meloxicam
• Brand Names Available In Australia: Mobic and generics (confirm product name on dispensing label)
• ATC Code: M01AC06
• Forms & Dosages: Oral tablets 7.5mg and 15mg; oral suspension 7.5mg/5mL; capsules 5mg and 10mg; IV solution 30mg/mL (single‑use vials)
• Manufacturers In Australia: not specified
• Registration Status In Australia: Listed as a prescription medicine in Australia
• OTC / Rx Classification: Prescription‑only (Rx) in all major markets

Critical Warnings And Restrictions

Are you worried about serious side effects or whether meloxicam is safe for you?

Meloxicam (INN: meloxicam; ATC M01AC06) is a prescription NSAID with known gastrointestinal, renal and cardiovascular risks.

Absolute contraindications include known hypersensitivity to meloxicam or other NSAIDs and prior NSAID‑induced asthma or urticaria.

Do not use meloxicam if you have active gastrointestinal bleeding or perforation, or if you need pain control immediately after coronary artery bypass graft (CABG) surgery.

Avoid meloxicam in severe hepatic or renal failure.

• Contraindications: Known NSAID allergy, NSAID‑related asthma/urticaria, active GI bleeding/perforation, post‑CABG pain, severe hepatic or renal failure.
• High‑Risk Checks: Age ≥65, current anticoagulant therapy, history of peptic ulcer, uncontrolled hypertension, heart disease.

Checklist For Pre‑Prescription Screening:

• Review renal function (eGFR/creatinine).
• Ask about past GI ulcers or bleeding.
• Assess cardiovascular risk and current BP control.
• List all anticoagulants, antiplatelets and SSRIs/SNRIs.

Q&A — “Can I Drive After Taking It In Australia?”

If meloxicam makes you dizzy, drowsy or blurs your vision you must not drive or operate heavy machinery.

Follow Australian workplace safety rules and your employer’s policies when tasks require full alertness.

Stop driving and seek advice if you experience new dizziness, visual disturbance or severe drowsiness after starting meloxicam.

For workplace guidance, check your employer or Safe Work Australia policies if unsure about fitness for duty.

Seek urgent care for signs of GI bleeding (black or bloody stools), chest pain or sudden breathlessness.

Usage Basics

Wondering what meloxicam is called and how it’s regulated here?

Meloxicam is the International Nonproprietary Name (INN) for the active ingredient in products commonly referred to as Mobic and generics.

Brand names internationally include Mobic, Movalis and Meloxicamum; in Australia it is supplied mainly as generics and occasional branded products — always confirm the dispensing label.

Classification is prescription‑only and regulated by the Therapeutic Goods Administration (TGA).

Some meloxicam formulations and indications may be eligible for PBS listing for chronic osteoarthritis or rheumatoid arthritis under specific criteria — check current PBS listings before assuming subsidy.

INN

Meloxicam

Brand Names

Mobic (reference), Movalis, Meloxicamum, and generics — confirm locally.

Pharmacists should confirm ARTG entries and PBS details at dispensing and counsel about generic interchangeability and cost.

Dosing Guide

Not sure what dose you or a patient should take?

Typical adult dosing for osteoarthritis and rheumatoid arthritis is 7.5–15mg orally once daily, starting at the lowest effective dose — often 7.5mg daily.

IV meloxicam in hospital settings is typically a single 30mg dose for acute moderate–severe pain.

Paediatric dosing where approved is 0.125mg/kg once daily (maximum 7.5mg) for children aged two years and older.

Elderly patients commonly start at 7.5mg/day and need monitoring of renal function, blood pressure and falls risk.

Renal impairment: avoid in severe renal failure or dialysis; for mild‑to‑moderate impairment use the lowest effective dose and monitor.

Hepatic impairment: use with caution and consider dose reduction or avoidance in moderate to severe disease.

• Checklist For Prescriber Dose Decision: Age, renal function, hepatic function, other medicines (anticoagulants, SSRIs, ACE inhibitors/ARBs, diuretics), indication severity.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless the next dose is near.

Do not double up doses to make up for a missed one.

Contact your pharmacist or prescriber if you are unsure after missing multiple doses.

Interaction Chart

Are you taking other medicines or supplements that could cause trouble with meloxicam?

Alcohol raises the risk of gastrointestinal bleeding when combined with meloxicam, so counsel patients to limit alcohol while taking this medicine.

Caffeine does not have a major pharmacokinetic interaction but can exacerbate dyspepsia in some people.

Clinician Checklist: always check full medication list including over‑the‑counter medicines and supplements such as fish oil and turmeric.

User Reports And Trends

What do Australian patients say about meloxicam in practice?

Common patient feedback highlights effective relief for osteoarthritis pain and the convenience of once‑daily dosing thanks to a long half‑life of approximately 20 hours.

Many patients report gastric upset or dyspepsia and some require PPI co‑therapy to manage symptoms.

Other reported effects include mild dizziness and peripheral oedema such as swollen ankles.

Price sensitivity is common and patients often seek PBS‑subsidised options or generics from major chains such as Chemist Warehouse or Priceline.

Rural patients report barriers to immediate GP scripts and limited access to IV formulations which are hospital‑only, while urban patients more often use telehealth e‑prescriptions.

• Pros From Patient Reports: effective pain control, once‑daily dosing, familiar brand name Mobic.
• Cons From Patient Reports: dyspepsia, dizziness, cost concerns, access to hospital‑only IV product.

Pharmacists should document suspected adverse events and report via the TGA Adverse Event Reporting System.

Access And Purchase Options

How can patients in Australia get meloxicam and what should they expect?

Meloxicam is dispensed by community pharmacies nationwide including major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart, plus independent pharmacies.

Oral formulations are commonly stocked, while IV meloxicam is hospital‑only.

Telehealth and electronic prescriptions are widely accepted and many pharmacies will deliver or ship to rural areas — check prescription validity and dispensing limits.

PBS listings and authority requirements can alter out‑of‑pocket cost, so verify PBS status before dispensing.

Patient Checklist For Ordering: valid prescription, ID if required, check storage during transit, arrange pharmacist counselling at delivery.

In our online pharmacy, mobic is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Mechanism And Pharmacology

How does meloxicam relieve pain and what does that mean for safety?

Meloxicam is an oxicam non‑steroidal anti‑inflammatory drug that preferentially inhibits cyclo‑oxygenase‑2 (COX‑2) over COX‑1 at therapeutic doses.

By reducing prostaglandin synthesis, meloxicam decreases inflammation and pain.

The long plasma half‑life of about 20 hours supports once‑daily dosing and sustained effect.

Onset of anti‑inflammatory benefit may be slower than short‑acting NSAIDs, but analgesia is maintained across the day.

Oral formulations are well absorbed and the IV product is used to achieve rapid plasma concentrations for acute pain in hospital settings.

• COX‑1 vs COX‑2: COX‑2 preference may offer fewer GI effects than non‑selective NSAIDs, but cardiovascular risks remain.
• Clinical Implications: once‑daily dosing, need to monitor renal and hepatic function, and be cautious in patients with CV risk.

Indications And Off‑Label Uses

What is meloxicam officially approved for and when might clinicians use it differently?

Approved indications include chronic management of osteoarthritis and rheumatoid arthritis in adults.

IV meloxicam is approved for single‑dose use for acute moderate‑to‑severe postoperative pain in adults in hospital settings.

Paediatric dosing is approved in some regions for juvenile rheumatoid arthritis in children aged two years and older; check ARTG and product information for local Australian approvals.

Off‑label uses sometimes considered by specialists include other inflammatory musculoskeletal conditions when alternatives are unsuitable, but these require documentation and monitoring.

Off‑label Prescribing Steps: document clinical rationale, obtain informed consent, set a monitoring plan and record follow‑up reviews.

Key Clinical Findings

What do recent Australian and international studies say about meloxicam?

Clinical data from 2022–2026 continue to show meloxicam is effective for osteoarthritis and rheumatoid arthritis with analgesic effects comparable to other NSAIDs.

Advantages include once‑daily dosing due to a long half‑life which improves adherence for some patients.

Safety analyses reaffirm the class risks of NSAIDs: increased gastrointestinal bleeding and cardiovascular events in at‑risk people, with risk related to dose and duration.

Studies suggest COX‑2 preferential agents may have a modestly lower GI event rate compared with non‑selective NSAIDs, while cardiovascular risks remain a concern.

Real‑world Australian pharmacoepidemiology emphasises monitoring needs in elderly patients and those on multiple medicines.

• IV meloxicam single dose provides postoperative analgesia benefits versus placebo in trials but requires bleeding‑risk assessment.
• Recommendation: consult TGA and current therapeutic guidelines for up‑to‑date guidance.

Alternatives Matrix

Which medicines might be used instead of meloxicam and how do they compare?

Checklist For Choosing An Alternative: assess patient CV and GI risk, renal function, concurrent drugs and PBS subsidy options.

Always aim for the lowest effective dose for the shortest necessary duration.

Common Questions

What do patients typically ask at the pharmacy about meloxicam?

• How long until it works? Analgesic effects may begin within hours to days, while full anti‑inflammatory benefit can take several days.
• Can I take meloxicam with aspirin? Avoid combining unless aspirin is low‑dose cardioprotective — discuss with prescriber due to increased GI risk.
• Is long‑term use safe? Long‑term use can be safe with regular monitoring and risk management of GI, CV and renal effects.
• Can I use it for period pain? It’s not a common first‑line option for young healthy adults; discuss alternatives such as ibuprofen.
• How to minimise stomach upset? Take with food and consider a PPI for those with prior peptic ulcer disease.

Pharmacist Counselling Checklist: confirm allergies and pregnancy/breastfeeding status, review medications and supplements, explain red‑flag symptoms and monitoring needs, provide storage and adherence advice.

Price And Access Comparison

How much will meloxicam cost and where is it easiest to buy?

Access Checklist: confirm prescription validity, check PBS concession card for reduced cost, ask about delivery or collection options and emergency supply rules for continuity of therapy.

Registration And Regulation

Who regulates meloxicam in Australia and what must clinicians report?

Meloxicam is registered as a prescription medicine in Australia and product registrations should be confirmed via the ARTG for up‑to‑date status.

The TGA monitors safety and adverse events and clinicians and pharmacists should report suspected serious reactions using the TGA Adverse Event Reporting System.

PBS subsidy and any authority (restricted) prescribing requirements change over time so check the PBS Schedule and Medicare information before prescribing or dispensing.

• Regulatory Actions: ADR reporting, ARTG checks, compliance with labelling and prescription requirements.
• Prescriber Checklist: confirm ARTG entry, determine if PBS authority is required, record concession details and supply justification for chronic therapy.

Storage And Handling

How should meloxicam be stored at home and handled in Australian pharmacies?

Store oral meloxicam at 20–25°C and protect from moisture and light.

Advise patients not to keep tablets in bathrooms or cars where heat and humidity are common in Australian conditions.

Keep medicines in the original container away from children and pets.

Oral suspensions should be shaken well before use and discarded after the expiry date or if the appearance changes.

IV vials require hospital pharmacy handling and manufacturer cold‑chain instructions where applicable; single‑use vials must be used aseptically and discarded if contaminated.

Disposal Recommendation: return unused medicines to a pharmacy for safe take‑back.

Guidelines For Proper Use

What will the pharmacist tell you when supplying meloxicam?

Counselling should be patient‑centred and begin with screening for GI, CV and renal risk, plus pregnancy and breastfeeding status.

Review all medicines and supplements and explain dosing, missed‑dose rules and what to do for suspected overdose.

List red‑flag symptoms clearly: black or bloody stools, severe abdominal pain, chest pain, sudden breathlessness or unilateral leg swelling.

Emphasise using the lowest effective dose for the shortest time, and the need for periodic review if ongoing therapy is considered.

• Monitoring Intervals: baseline renal function and blood pressure, repeat testing as clinically indicated for long‑term use.
• Responsibilities: GP / specialist orders monitoring tests, pharmacist reinforces adherence and flags concerns, patient reports symptoms promptly.

Encourage non‑pharmacological options such as exercise, weight management and physiotherapy where appropriate.

Delivery Across Australia